Topology Health is testing their AI-powered toolkit that helps healthcare providers integrate digital health apps for efficient data flow.
From ideation to commercialization, Cosm’s journey in advancing women’s pelvic health as it enters the Canadian market and beyond!
Femtech startup Cosm Medical is changing women's pelvic health with a medical device that combines software, AI and 3D printing.
Innovation Factory Expands Support for High-Potential Life Science Innovators by Introducing Medtech Manufacturing Funding Program
With support from the Government of Canada, Innovation Factory launches the Canadian Medtech Alliance (CAMEDA) program.
2022 Synapse Cluster Report: A Year of Breakthroughs and Boundless Possibilities for Hamilton’s Life Sciences Cluster
The 2022 Cluster Report summarizes the dynamic growth of the Hamilton life sciences ecosystem, highlighting the integration of organizations that contribute to its vibrant community.
Innovation Factory partners with HaloHealth to bridge the gap between healthcare startups and clinical expertise
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Altis Labs to Develop Digital Twins for Clinical Trials in Partnership with Leading Research Institutions and Global Biopharmaceutical Companies
Altis Labs announces today that it is leading an international coalition focused on the development and implementation of digital twins in clinical trials.
Lactiga Receives FDA ‘Rare Pediatric Disease’ Designation for Groundbreaking Mucosal Immunoglobulin Therapy for CVID
LCTG-001 on course to be the first FDA-approved biologic from human milk for pediatric patients with Common Variable Immunodeficiency.
PreOperative Performance Enters the SOPHIE Program to Fuel Collaboration with Ontario-Based Radiology Researchers
Through the SOPHIE program, PreOperative Performance will enter a 12-month co-development partnership with The Research Institute of St. Joe’s Hamilton (RSJH) to evaluate technology that aims to help radiology groups make better quality measurements of MRI machines. This press release was originally shared by PreOperative Performance
Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy
This press release was originally published by Fusion Pharmaceuticals on April 12, 2023. Read the original post here. FPI-2068 is a Bispecific Targeted Alpha Therapy (TAT) designed to Precisely Deliver Radiation to Tumor Cells HAMILTON, ON and BOSTON, April 12, 2023 /– Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage